BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21237164)

  • 1. The role of the C-terminus of human α-synuclein: intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers.
    Hong DP; Xiong W; Chang JY; Jiang C
    FEBS Lett; 2011 Feb; 585(3):561-6. PubMed ID: 21237164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C; Chang JY
    Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.
    Ulrih NP; Barry CH; Fink AL
    Biochim Biophys Acta; 2008 Oct; 1782(10):581-5. PubMed ID: 18692132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
    Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
    Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine quinones interact with alpha-synuclein to form unstructured adducts.
    Bisaglia M; Tosatto L; Munari F; Tessari I; de Laureto PP; Mammi S; Bubacco L
    Biochem Biophys Res Commun; 2010 Apr; 394(2):424-8. PubMed ID: 20226175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation.
    Ferreon AC; Deniz AA
    Biochemistry; 2007 Apr; 46(15):4499-509. PubMed ID: 17378587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein.
    Hokenson MJ; Uversky VN; Goers J; Yamin G; Munishkina LA; Fink AL
    Biochemistry; 2004 Apr; 43(15):4621-33. PubMed ID: 15078109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state.
    Zhang JG; Matthews JM; Ward LD; Simpson RJ
    Biochemistry; 1997 Mar; 36(9):2380-9. PubMed ID: 9054543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils.
    Yu WB; Jiang T; Lan DM; Lu JH; Yue ZY; Wang J; Zhou P
    Arch Biochem Biophys; 2012 Jul; 523(2):144-50. PubMed ID: 22575388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
    Liu Y; Breslauer K; Anderson S
    Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
    Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.